BCR-ABL1 T315I mutation, a negative prognostic factor for the terminal phase of chronic myelogenous leukemia treated with first- and second-line tyrosine kinase inhibitors, might be an indicator of allogeneic stem cell transplant as the treatment of
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Ciprian Ionuţ Tomuleasa Ioana Berindan-Neagoe Delia Dima Ioana-Codruța Frinc Mariana Patiu Andrei Cucuianu Bobe Petrushev |
| Publication date | August 19, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |